Prix Galien USA Names HUMIRA Best Biotechnology Product Abbott (NYSE: ABT), a leader in the treatment of autoimmune diseases, has received the 2007 Galen Prize for Best Biotechnology Product for HUMIRA (R) (adalimumab), the first approved fully human antibody. HUMIRA is approved for use in the treatment of moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and moderate to severe Crohn's disease. The Galen Prize, considered an equivalent to the Nobel Prize and
“Marinated shredded chicken with jelly fish served cold” @ Yok Chinese Restaurant
—
Yok Chinese Restaurant of the Emerald Hotel would like to invite you t...